Recalled but Not Found

When a medical device is recalled in the United States, the process is slow, opaque, and frequently fails to reach all affected devices. The average Class I recall — indicating a reasonable probability of death or serious injury — takes 516 days from initiation to termination. A central contributor is the failure of the Unique Device Identification (UDI) system to achieve its intended purpose: although manufacturers label devices with UDIs as required, hospitals and payers have not adopted UDI tracking in their inventory and procurement systems. When a recall is issued, healthcare facilities cannot electronically identify which specific devices in their inventory are affected, forcing manual searches through warehouses and patient records.

In 2024, recall events rose 8.6% and impacted units jumped 55% to approximately 440 million — the highest in three years. From FY 2020 to 2024, the FDA oversaw 3,934 voluntary medical device recalls but could not meet its 3-month termination goal due to resource constraints. Delays in recall execution mean that recalled devices remain in active clinical use for months or years after safety issues are identified, exposing patients to devices known to be defective and leaving clinicians unaware of recalls affecting their practice.

The UDI Final Rule (2013) required manufacturers to include UDIs on device labels, but it imposed no corresponding obligation on hospitals or payers to track UDIs in their electronic systems. The result is that UDI is, for practical postmarket surveillance purposes, "functionally useless." The FDA launched a Communications Pilot in 2024 to provide early alerts for potentially high-risk device removals, and CDRH maintains a public Medical Device Recall Database. Some large health systems have begun UDI scanning at point of implant, but this is not standard practice and covers only implantable devices. All device recalls in the United States remain voluntary — the FDA cannot mandate a recall, only request one — creating additional delays when manufacturers are slow to act. Only 25% of Class I recall notices included UDI information as of 2024.

A lightweight, interoperable UDI scanning and tracking module that integrates with existing hospital EHR and supply chain systems — without requiring a full infrastructure overhaul — could close the identification gap. Alternatively, a regulatory mandate requiring hospitals to capture UDI data at point of use, combined with a national recall notification system that pushes alerts directly to facilities with affected devices, would transform the current manual search process into automated identification. Models exist in pharmaceutical track-and-trace systems mandated under the Drug Supply Chain Security Act.

A student team could prototype a UDI-based recall alert system: a lightweight application that ingests the FDA recall database, matches against a simulated hospital device inventory, and generates automated notifications identifying affected units by location. A complementary project could analyze the FDA recall database to quantify the relationship between recall completion time and UDI information availability. Relevant disciplines include health informatics, supply chain engineering, database design, and UX design for clinical workflows.